Protective effect of Guanxinning on antipsychotic-induced cardiac impairment in long-term hospitalized psychiatric patients

Figure 1 Comparison of cardiac indicators before and after treatment in the Guanxinning intervention group. A: Main indicators; B: Key indicators; C: Secondary outcomes. QTc: Corrected QT; E/A ratio: Early maximal ventricular filling velocity/atrial maximal ventricular filling velocity; LVEF: Left ventricular ejection fraction; CTNI: Cardiac troponin I; LVEDD: Left ventricular end-diastolic diameter; cTnI: Cardiac troponin I; BNP: B-type natriuretic peptide; NT-proBNP: High N-terminal pro-B-type natriuretic peptide; SOD: Superoxide dismutase; MDA: Malondialdehyde; GSH-Px: Glutathione peroxidase; Hs-CRP: High-sensitivity C-reactive protein; IL-6: Interleukin-6; TNF-α: Tumor necrosis factor-alpha; HbA1c: Hemoglobin A1c.